cefixime has been researched along with Syndrome in 3 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cefixime was kept for patients not responding to the first GU treatment." | 1.31 | Cost-effectiveness of management strategies for acute urethritis in the developing world. ( Crabbé, F; de Clerck, M; Laga, M; Vuylsteke, B, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Novembre, E | 1 |
| Mori, F | 1 |
| Barni, S | 1 |
| Pucci, N | 1 |
| Garnier, A | 1 |
| El Marabet, el H | 1 |
| Kwon, T | 1 |
| Peuchmaur, M | 1 |
| Mourier, O | 1 |
| Baudouin, V | 1 |
| Deschênes, G | 1 |
| Loirat, C | 1 |
| Crabbé, F | 1 |
| Vuylsteke, B | 1 |
| de Clerck, M | 1 |
| Laga, M | 1 |
3 other studies available for cefixime and Syndrome
| Article | Year |
|---|---|
Drug-induced enterocolitis syndrome (DIES).
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Child; Dairy Products; Diarrhea; Drug Eruptions; Drug | 2014 |
Acute renal failure in a 3-year-old child as part of the drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome following hepatitis A.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cefixime; Child, Prescho | 2008 |
Cost-effectiveness of management strategies for acute urethritis in the developing world.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cost-Benefit Analysis; Decisi | 2000 |